NO171215C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme diselenobis-benzosyreamider - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk virksomme diselenobis-benzosyreamiderInfo
- Publication number
- NO171215C NO171215C NO873231A NO873231A NO171215C NO 171215 C NO171215 C NO 171215C NO 873231 A NO873231 A NO 873231A NO 873231 A NO873231 A NO 873231A NO 171215 C NO171215 C NO 171215C
- Authority
- NO
- Norway
- Prior art keywords
- diselenobis
- nitro
- alkoxy
- halogen
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863626554 DE3626554A1 (de) | 1986-08-06 | 1986-08-06 | Diselenobis-benzoesaeureamide primaerer heterocyclischer amine, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische praeparate |
Publications (4)
Publication Number | Publication Date |
---|---|
NO873231D0 NO873231D0 (no) | 1987-08-03 |
NO873231L NO873231L (no) | 1988-02-08 |
NO171215B NO171215B (no) | 1992-11-02 |
NO171215C true NO171215C (no) | 1993-02-10 |
Family
ID=6306768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO873231A NO171215C (no) | 1986-08-06 | 1987-08-03 | Analogifremgangsmaate for fremstilling av terapeutisk virksomme diselenobis-benzosyreamider |
Country Status (19)
Country | Link |
---|---|
US (1) | US4910313A (de) |
EP (1) | EP0257306B1 (de) |
JP (1) | JPH0830060B2 (de) |
KR (1) | KR960001202B1 (de) |
AT (1) | ATE56436T1 (de) |
AU (1) | AU598285B2 (de) |
CA (1) | CA1303038C (de) |
DD (1) | DD261597A5 (de) |
DE (2) | DE3626554A1 (de) |
DK (1) | DK169407B1 (de) |
ES (1) | ES2017483B3 (de) |
FI (1) | FI85018C (de) |
GR (1) | GR3001180T3 (de) |
HU (1) | HU197753B (de) |
IE (1) | IE60366B1 (de) |
NO (1) | NO171215C (de) |
PT (1) | PT85501B (de) |
SU (1) | SU1597097A3 (de) |
ZA (1) | ZA875821B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128365A (en) * | 1989-07-19 | 1992-07-07 | The Trustees Of Columbia University In The City Of New York | Compounds having glutathione peroxidase activity and use thereof |
DE3937170A1 (de) * | 1989-11-08 | 1991-05-16 | Nattermann A & Cie | Benzylselenobenzamide von aminopyridinen und picolylaminen |
DE3937171A1 (de) * | 1989-11-08 | 1991-05-16 | Nattermann A & Cie | Picolylselenobenzamide von aminopyridinen, anilinen und picolylaminen |
KR100214453B1 (ko) * | 1992-01-17 | 1999-08-02 | 스즈키 다다시 | 경피적 관상동맥 형성술 후의 재협착 억제제 |
FR2757857B1 (fr) * | 1996-12-27 | 1999-04-23 | Oxis International Sa | Diselenures et selenosulfures aromatiques, leur preparation et leurs utilisations, notamment therapeutiques |
EP1174423A4 (de) | 1999-03-31 | 2008-03-19 | Arne Holmgren | Substrate für die thioredoxin reduktase |
US7776925B2 (en) * | 2002-03-06 | 2010-08-17 | Duke University | Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria |
US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3027075A1 (de) * | 1980-07-17 | 1982-02-18 | A. Nattermann & Cie GmbH, 5000 Köln | Benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
DE3027073C2 (de) * | 1980-07-17 | 1985-03-07 | A. Nattermann & Cie GmbH, 5000 Köln | Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on |
DE3027074A1 (de) * | 1980-07-17 | 1982-02-18 | A. Nattermann & Cie GmbH, 5000 Köln | Benzisoselenazolon enthaltende pharmazeutische praeparate und ihre verwendung |
DE3226284A1 (de) * | 1982-07-14 | 1984-01-19 | A. Nattermann & Cie GmbH, 5000 Köln | Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
EP0165534B1 (de) * | 1984-06-22 | 1989-03-15 | A. Nattermann & Cie. GmbH | S-(Carbamoyl-phenylselenyl)-Derivate des Glutathions und von Aminomercaptocarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
DE3443467A1 (de) * | 1984-11-29 | 1986-05-28 | A. Nattermann & Cie GmbH, 5000 Köln | Mercaptanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
EP0198277B1 (de) * | 1985-04-12 | 1989-05-03 | A. Nattermann & Cie. GmbH | Diselenobis-benzoesäureamide primärer und sekundärer Amine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
DE3515272C2 (de) * | 1985-04-27 | 1993-10-14 | Nattermann A & Cie | Benzisoselenazolone, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
-
1986
- 1986-08-06 DE DE19863626554 patent/DE3626554A1/de not_active Withdrawn
-
1987
- 1987-07-23 DE DE8787110648T patent/DE3764910D1/de not_active Expired - Fee Related
- 1987-07-23 EP EP87110648A patent/EP0257306B1/de not_active Expired - Lifetime
- 1987-07-23 AT AT87110648T patent/ATE56436T1/de not_active IP Right Cessation
- 1987-07-23 ES ES87110648T patent/ES2017483B3/es not_active Expired - Lifetime
- 1987-07-27 IE IE203387A patent/IE60366B1/en not_active IP Right Cessation
- 1987-07-30 CA CA000543452A patent/CA1303038C/en not_active Expired - Fee Related
- 1987-08-03 NO NO873231A patent/NO171215C/no unknown
- 1987-08-04 FI FI873383A patent/FI85018C/fi not_active IP Right Cessation
- 1987-08-05 HU HU873576A patent/HU197753B/hu not_active IP Right Cessation
- 1987-08-05 DK DK409087A patent/DK169407B1/da not_active IP Right Cessation
- 1987-08-06 KR KR1019870008679A patent/KR960001202B1/ko not_active IP Right Cessation
- 1987-08-06 US US07/082,438 patent/US4910313A/en not_active Expired - Fee Related
- 1987-08-06 AU AU76651/87A patent/AU598285B2/en not_active Ceased
- 1987-08-06 ZA ZA875821A patent/ZA875821B/xx unknown
- 1987-08-06 SU SU874203234A patent/SU1597097A3/ru active
- 1987-08-06 JP JP62195406A patent/JPH0830060B2/ja not_active Expired - Lifetime
- 1987-08-06 DD DD87305765A patent/DD261597A5/de not_active IP Right Cessation
- 1987-08-06 PT PT85501A patent/PT85501B/pt active IP Right Revival
-
1990
- 1990-12-11 GR GR90401048T patent/GR3001180T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO873231L (no) | 1988-02-08 |
JPH0830060B2 (ja) | 1996-03-27 |
DD261597A5 (de) | 1988-11-02 |
ATE56436T1 (de) | 1990-09-15 |
US4910313A (en) | 1990-03-20 |
PT85501B (pt) | 1990-06-29 |
IE60366B1 (en) | 1994-07-13 |
GR3001180T3 (en) | 1992-06-30 |
DK409087D0 (da) | 1987-08-05 |
KR960001202B1 (ko) | 1996-01-24 |
KR880002889A (ko) | 1988-05-12 |
ZA875821B (en) | 1988-02-10 |
HU197753B (en) | 1989-05-29 |
ES2017483B3 (es) | 1991-02-16 |
AU598285B2 (en) | 1990-06-21 |
EP0257306B1 (de) | 1990-09-12 |
AU7665187A (en) | 1988-02-11 |
IE872033L (en) | 1988-02-06 |
JPS6379875A (ja) | 1988-04-09 |
DK169407B1 (da) | 1994-10-24 |
FI85018B (fi) | 1991-11-15 |
FI85018C (fi) | 1992-02-25 |
NO171215B (no) | 1992-11-02 |
PT85501A (en) | 1987-09-01 |
SU1597097A3 (ru) | 1990-09-30 |
FI873383A (fi) | 1988-02-07 |
DE3764910D1 (de) | 1990-10-18 |
FI873383A0 (fi) | 1987-08-04 |
EP0257306A1 (de) | 1988-03-02 |
CA1303038C (en) | 1992-06-09 |
NO873231D0 (no) | 1987-08-03 |
HUT44572A (en) | 1988-03-28 |
DE3626554A1 (de) | 1988-02-18 |
DK409087A (da) | 1988-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO174296C (no) | Analogifremgangsmåte til fremstilling av terapeutisk aktive 1-indolylalkyl-4-(substituert-pyridinyl)piperaziner | |
NO883587L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolderivater. | |
NO171215C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme diselenobis-benzosyreamider | |
IT1229569B (it) | Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono. | |
ATE18196T1 (de) | 1,4-acyloxynaphthalenderivate, diese enthaltende kompositionen, verfahren fuer ihre herstellung und zwischenprodukte dafuer. | |
DK163144C (da) | Diethylaminoalkoxybenzhydrolderivater og farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat og fremgangsmaade til fremstilling heraf | |
ES8705411A1 (es) | Procedimiento para preparar derivados de 1-piperazinacarboxamida | |
NO881835L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser. | |
DK246180A (da) | Fremgangsmaade til fremstilling af paromomycinderivater | |
NO161493C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,6-nafthyridinderivater. | |
SE8005686L (sv) | Nya halogenvinkamonderivat jemte sett for deras framstellning | |
NO159927C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aromatiske aminoacetylener. | |
ATE52776T1 (de) | 1-phenyl-3-benzazepine. | |
NO173783C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, kondenserte heterodykliske derivater av 1,2,3,4-tetrahydroakridiner | |
FI103885B1 (fi) | Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä | |
LV5491A3 (lv) | 2-tiazolidinona atvasinajumu iegusanas panemiens | |
ES557208A0 (es) | Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina | |
SE7910430L (sv) | Cyklododekanderivat jemte sett for deras framstellning | |
DE3884878D1 (de) | Uricosuretische Zusammensetzung. | |
IT1210914B (it) | Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico. | |
ES2056211T3 (es) | Derivados de acilsulfonamida de acidos alfa-carbocicliltoluicos usados como antagonistas de leucotrienos. | |
GB979007A (en) | Benzenesulphonyl-semicarbazides and process for their manufacture |